Tamsi, Aurea D.
HRN: 24-78-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2024
CEFTRIAXONE 1G (VIAL)
04/02/2024
04/08/2024
IV
1gram
Q12hrs
CAP-LR; Fracture Losed Right Pelvis; Abdominal Mass Probably Benign; DM Type 2 Uncontrolled
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes